CR6086
CR6086 Uses, Dosage, Side Effects, Food Interaction and all others data.
CR6086 is under investigation in clinical trial NCT03163966 (A Study of the EP4 Antagonist CR6086 in Combination With Methotrexate, in Dmard-naïve Patients With Early Rheumatoid Arthritis).
| Trade Name | CR6086 |
| Generic | CR6086 |
| Type | |
| Formula | C26H27F3N2O3 |
| Weight | Average: 472.508 Monoisotopic: 472.197377226 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here CR6086
